mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-09 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.25 |
1e-08 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.38 |
2e-08 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-08 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-07 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-07 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-07 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |